Abstract: A hip traction device and associated methods is disclosed. Such a device may include a base having a proximal end and a distal end, a guide coupled to the base, a carrier configured to move along the guide, a tensioner coupled to the base and configured to provide a force to the carrier to move the carrier toward the distal end of the base, causing a leg to be put in tension, and a single body coupling mechanism being removably attached to the carrier and being configured to securely attach to a lower portion of a leg when the body coupling mechanism is detached from the carrier.

Abstract: A spinal decompression belt for reducing the pressure exerted on a user's ankles when using an inversion table. The spinal decompression belt includes an elongated pad to be disposed around a user's abdomen and that can be secured by overlapping the end portions thereof. A cushioning member is removably securable to the interior of the first end for providing additional support to the user's abdomen. The elongated pad further includes an elongated strap therearound that includes an adjustable fastener for securing the belt to the user. An extension strap having an adjustable fastener thereon extends from the front of the elongated pad to the rear thereof and can be positioned between the legs of the user. The extension strap further includes a fastener, such as a ring, having a pair of ankle bar straps thereon that can be wrapped around the ankle bars of an inversion table.

Abstract: The invention relates to an apparatus (1) for unloading a user's body weight during a physical activity of said user (4), particularly for gait training of said user (4), comprising: a plurality of ropes (41, 42, 43, 44), wherein each rope (41, 42, 43, 44) extends from an associated drive unit (510, 520, 530, 540), is deflected by a passively displaceable deflection device, e.g.

Abstract: An articulated grip pad is disclosed which includes a vertical supporting member that has a generally spherical bottom end. The crutch also includes a gripping pad having a bore. The generally spherical end of the vertical support is securely received into the bore.

Abstract: A walking aid device includes a support body inclusive of a plurality of support elements extending toward the ground. Each support element is coupled to a caster and a brake unit. Each brake unit has a clutching surface. The clutching surface controllably clutches a wheel of the caster or the ground to thereby generate friction for stopping the walking aid device.

Abstract: A system and method for assisting a visually impaired user including an imaging device, a processing unit for receiving images from the imaging device and converting the images into signals for use by one or more controllers, and one or more vibro-tactile devices, wherein the one or more controllers activates one or more of the vibro-tactile devices in response to said signals received from the processing unit. The system preferably includes a lanyard to be worn around the neck of the user such that a first vibro-tactile device is arranged on the right side of the user's neck, a second vibro-tactile device on a left side of the user's neck, and a third vibro-tactile device at the back portion of the user's neck. The vibro-tactile devices are activated depending on a determined position in front of the user of an object and the distance from the user to the object.

Abstract: A device for facilitating or enhancing proprioceptive feedback during breathing and related exercises includes a user attachment component attachable to a user about the thorax. Two elongate tensile members are connected at proximal ends to the user attachment component at points essentially just below the armpits of a user. These two elongate tensile members are connectable at their distal ends to the feet of the user. Another two tensile members are connected at their proximal ends to a back portion or strap of the harness and at their distal ends to or about the user's hands.

Abstract: Single- or dual-bladder devices for automated delivery of remote ischemic conditioning treatment via partial limb occlusion involve various methods of operating the cuff in which partial or full limb occlusion is achieved during the periods of cuff inflation. Achieving clinical benefits of remote ischemic conditioning without extended cessation of limb blood flow are advantageous due to lower required cuff pressure and reduced risk of clot formation in the limb vasculature.

Abstract: A exercise roller device including a center roller portion provided with shaped end roller portions, and the center roller portion provided with a centered circumferential groove. A method of making the exercise roller device.

Abstract: An elevation device used in the performance of cardiopulmonary resuscitation (CPR) includes a base and an upper support pivotably coupled to the base. The upper support is configured to elevate the individual's upper back, shoulders and head when pivoted. The upper support is expandable lengthwise. The upper support includes a neck support that is configured to support the individual's spine in a region of the individual's C7 and C8 vertebrae throughout elevation of the upper back, shoulders and head.

Abstract: While such systems and methods can include any suitable component, in some cases, they include a first and a second piece of sauna housing and a sauna heater. In some such cases, the second piece of sauna housing slidingly couples with the first piece to define an interior sauna chamber. Additionally, in some cases, a first portion of the second piece of sauna housing is configured to slidably fit within the first piece such that a volume of the sauna chamber is configured to increase and decrease, respectively, when the second piece is moved into an extended position or when the second piece is moved from the extended position into a collapsed position in which the second piece nests within the first piece. In some cases, the first and second pieces include a ceiling that is configured to extend over a user within the sauna chamber. Other implementations are described.

Abstract: A blood storage container for the anaerobic storage of blood, having enhanced sealing methods and materials for the preservation of stored blood is provided.

Abstract: A liquid medication dispensing machine capable of stirring a liquid medication contained in a liquid medication bottle in the machine with a simple structure is provided. The liquid medication dispensing machine supplying a liquid medication from a liquid medication bottle (23) containing the liquid medication to a prescription bottle includes a holder (78) holding a bottom (23B) of the liquid medication bottle (23), and a rotationally driving unit (61) generating rotary force and rotating the holder (78) and the liquid medication bottle (23) held by the holder (78) around a rotation axis (L3) extending along a center line (L2) of the liquid medication bottle (23).

Abstract: A drug container closure for mounting on an open-topped drug container to form a ready-to-use drug reconstitution assemblage for use with a needleless syringe. The drug container closure includes a drug container stopper for sealing the drug container and a fluid transfer member with an integral needleless syringe connector and a puncturing cannula. The fluid transfer member is manually disposed along a diametric inverted L-shaped track pair from an initial non-puncturing position to a puncturing position. The inverted L-shaped track pair includes one-way snap members to prevent a user returning the fluid transfer member to an earlier position and indicating progress of the user activation.

Abstract: A vial for storing multiple doses of a substance to be dispensed into one or more syringes or other delivery devices. The vial has a body, a variable-volume storage chamber within the body for storing multiple doses of the substance therein, and a one-way valve connectable in fluid communication with a syringe or other delivery device. The one-way valve is moveable relative to the body between first and second positions (i) one of which permits the valve to open so that substance from the variable-volume storage chamber can flow therethrough and into the syringe or other delivery device connected in fluid communication therewith, and (ii) one of which prevents the valve from opening.

Abstract: A drug vial safety device, including a cover that is securable to a drug vial is disclosed. The cover at least partially encloses at least a neck and a lid of the drug vial. The cover includes a port having a shape that restricts syringe access to the vial through the port to a syringe shaped to be compatible with the port shape.

Abstract: The device (1) has a housing (2), and a flexible bag arranged in the housing and intended to receive a liquid. A dispensing device, in particular an injection syringe (5), is also arranged in the housing, so that it is removable from the housing. A transfer channel (6) serves for direct or indirect transfer of the liquid from the bag into the dispensing device. At least one pressure plate (7) is also provided, which can be pressed against the bag in order to empty the bag. The pressure plate is preferably activated via a spring mechanism (16), which serves as energy accumulator. The device, according to the invention, makes it possible, with a few manoeuvres, to prepare an injection liquid and deliver it to the injection syringe, with the substances being brought together by a largely automated procedure.

Abstract: An enhanced medicine cup for use with a medicine bottle is disclosed, the medicine cup having a sipping straw running along a sidewall of the cup, the straw enabling a person to easily sip medicine from the bottom of the cup. The sipping straw extends upward beyond the sidewall, having a first opening at it's top end, and extends downward along the sidewall, being sealed at it's bottom end, and having instead a second opening near its bottom end in its sidewall that is in fluid communication with the inside of the cup via a corresponding opening near the bottom of the cup. Retaining protrusions are provided around the inner surface of the sidewall of the cup that engage with a cooperative ridge on the outer surface of a cap or a neck of a medicine bottle so as to removably retain the enhanced medicine cup on the medicine bottle.

Abstract: A medication dispensing cart having a computer and monitor, a work surface with pull out keyboard, and plural drawers arranged as a vertical series of cassettes that can be added as needed. The battery powered device uses software and pass codes for controlling access to each drawer, and requires a second pass code for any drawer designated to contain narcotics. Records can be kept of who dispenses what medication and when for each cart in a system of carts. The cart in the system is in wireless communication with a system administrator. Emails alerting the system administrator of low battery power, of a cart switching to off, of an attempted break-in, and of inventory and usage data are sent automatically by email.

Abstract: A dental composition comprising: a) about 1 to about 80% by weight of particulate material including: (i) calcium silicate, calcium aluminate, tetracalcium aluminoferrite, calcium phosphate, calcium sulfate, silica, alumina, calcium oxide, calcium hydroxide, or mixtures thereof; and b) about 1 to about 50% by weight liquid carrier including: (i) water-soluble polymer, (ii) surfactant, the surfactant is selected from the group consisting of alkyl sulfates, alkyl ether sulfates, and sarcosinates, and mixtures thereof; and (iii) water; wherein the particulate and liquid carrier being mixed together to form a hydrate gel material that can harden.

Abstract: The present technology provides a dry shampoo composition comprising clay, natural starches and a natural oil absorbent. Such dry shampoo compositions are highly absorbent, fine, light and resistant to clumping. In some embodiments, the dry shampoo compositions are useful as alternatives to conventional wet shampoo in methods for cleaning hair.

Abstract: The present invention relates to inorganic powder coated with biocompatible polymer and a cosmetic composition comprising same. More particularly, the present invention relates to an organic/inorganic composite powder in which the rough surface of the inorganic powder is treated with biocompatible polymer, thereby improving dispersibility and feeling of use and to a cosmetic composition comprising said composite powder so as to achieve improved feeling of use and tight adhesion when applied to the skin.

Abstract: Provided is an oral care composition comprising a phosphate/acrylate co-polymer, a whitening agent and an orally acceptable carrier and methods of using the same.

Abstract: A cosmetic composition for reducing fair regrowth from four to seven terpene alcohols and including four sesquiterpene alcohols for reducing hair regrowth.

Abstract: Cosmetic formulations including specific ester quats based on isopropanolamine are provided, as well as the use of these ester quats in cosmetics.

Abstract: The present invention relates to a composition, in particular a cosmetic composition, comprising, in a physiologically acceptable medium, at least glyceryl caprylate, 1,3-propanediol and phytic acid or any of the salts thereof, said composition being free from perlite. The present invention further relates to a composition, in particular a cosmetic composition, comprising, in a physiologically acceptable medium, at least glyceryl caprylate, 1,3-propanediol and phytic acid or any of the salts thereof.

Abstract: The present invention provides a method for removing a tattoo in a region of skin the method comprises administering to a least a portion of the tattoo a composition comprising an effective amount of a bisphosphonate and at least one pharmaceutically acceptable excipient to at least cause fading of the tattoo in said region.

Abstract: Described herein are dental compositions, articles of manufacture including such dental compositions, and methods of using such dental compositions. In some embodiments, the dental compositions include a combination of ascorbic acid with at least one of a hexametaphosphate and a beta glucans. In some instances, the dental compositions are included within an edible article, a chew, or an edible chew. Administration of the dental compositions to the oral cavity of a subject may reduce the gingival, plaque, and/or calculus scores of the subject over a defined time period.

Abstract: The present application describes personal care compositions, comprising a surfactant and agglomerated cellulose derivative, provided that the cellulose derivative has been agglomerated with a sufficient amount of carboxymethylcellulose as binder, and provided that the personal care composition is substantially free of glyoxal.

Abstract: A viscous composition of the present invention comprises specific cellulose fibers (A), (A?) and (A?) and the specific cellulose fibers (A), (A?) and (A?) are used with appropriate selection according to uses of a cosmetic composition, a gel-like composition and a spray composition. Therefore, in case where the composition is used as the cosmetic composition, a cosmetic composition which is excellent in shape retention ability and dispersion stability and excellent in water tolerance to satisfy the properties and the performance which is necessary for cosmetics is obtained. Additionally, in case where the composition is used as a gel-like composition, gel-state can be kept without separation or water release. Furthermore, in case where the composition is used as a spray composition, since it is possible to time-dependently keep stable gel state even if functional additives such as electrolytes, ionic substances, etc.

Abstract: Disclosed herein are cosmetic compositions comprising (a) at least one ethylenically unsaturated polymerizable compound and (b) at least one photoinitiator system comprising at least one photoinitiator having at least one absorption wavelength greater than about 350 nm. Also disclosed herein are methods of making up and/or enhancing the appearance of a keratinous substrate comprising (1) forming at least one film on the keratinous substrate by applying said cosmetic composition to the keratinous substrate and (2) exposing the film to UV-LED radiation.

Abstract: Disclosed are hair styling compositions comprising at least two latex polyurethane polymers, wherein at least one latex polyurethane polymer is a film-forming polymer, and at least one component chosen from thickening agents. Methods of styling the hair are also disclosed.

Abstract: The invention is directed to a personal care composition which contains a crosslinked ionic silicone network wherein the crosslinked ionic silicone network is formed by the ring-opening polymerization of oxirane moiety.

Abstract: Provided in various embodiments are compositions for topical application to the skin of a mammal, methods for their preparation, and their uses in skin care compositions to reduce adhesion of unwanted particles to the skin. When a hydrophobic non-volatile solvent and a hydrophobic non-volatile high melting point material with a melting point in the range of 60° C. and 100° C. are combined with a hydrophobic volatile solvent which compatibilizes the hydrophobic non-volatile solvent and the hydrophobic non-volatile high melting point material and the hydrophobic non-volatile high melting point material is selected to be at least partially incompatible with the hydrophobic non-volatile solvent in the absence of the hydrophobic volatile solvent, the resulting composition may be applied to skin to reduce adhesion of unwanted particles to the skin.

Abstract: Described herein are methods and compositions for increasing dermal concentrations of glycosaminoglycans (GAG), including hyaluronic acid. Exemplary methods involve a one-step protocol and a three-step protocol. Either method can be used over a 90-day treatment period.

Abstract: Disclosed are hair styling compositions comprising: (a) one or more latex polymers selected from acrylate latex polymers, polyurethane latex polymers, and mixtures thereof; and (b) a wax dispersion comprising: (i) particles having a volume-basis particle size distribution with peaks in the range of equal to or greater than 1 ?m up to about 100 ?m wherein the particles comprise at least one wax having a melting point of greater than 35° C.; (ii) a surfactant mixture comprising a nonionic surfactant and an ionic surfactant; (iii) an oil gellant; and (iv) water.

Abstract: Compositions for topical use and having a melanin synthesis-inhibiting activity that include an amount of a botanical extract of at least one of Aspalathus Linearis, Matricaria, Saxifraga, Astragalus, Taraxacum officinale/mongolicum, Ferula varia/foetida, Carthamus tinctorius, Sophora flavescentis, or Chrysanthemum morifolium effective to reduce melanin synthesis are described. Methods for inhibiting melanin synthesis and for skin whitening are also described.

Abstract: A depilatory composition for hair removal including beeswax, hydrogenated rosin, gum rosin, titanium dioxide, castor oil, and red or pink color. The composition is used at no lower than 95 degree Fahrenheit and removed at room temperature, easily spread and non-toxic.

Abstract: A cosmetic skin care composition for improving the appearance of aging skin. The composition is topically applied to a target area of skin where treatment is desired. The composition includes an effective amount of artichoke leaf extract and carob fruit extract in combination, and is applied for a period of time sufficient to improve the appearance of the aging skin.

Abstract: An injectable non-aqueous composition and a method of treating a vascular disease, the non-aqueous composition including: chitosan having a particle size of no greater than 50 ?m; alginate having a particle size of no greater than 50 ?m; and a non-aqueous carrier; wherein upon combination and injection into the vascular system of a subject, the composition causes a diseased portion of the vascular system to be absorbed into surrounding tissue.

Abstract: The present invention relates to a process for manufacturing an ophthalmic formulation of a carbonic anhydrase inhibitor, hydroxyl ethyl cellulose (HEC), and a beta-adrenergic antagonist for use in the treatment of ocular hypertension and glaucoma wherein the ophthalmic pharmaceutical formulation is devoid of benzalkonium chloride or any other preservatives. The present process for manufacturing is simpler, cost effective process to prepare the pharmaceutical ophthalmic formulation in a single tank, without the use of additional tanks that can be sterile filtered.

Abstract: Nutritional compositions that mimic whole foods and methods of using the nutritional compositions are provided. The nutritional compositions may include an increased number and variety of fruits and vegetables, an increased variety of macronutrient sources and an increased amount of other components that are found in whole foods. The nutritional compositions may also include ethnicity-specific meals and organic ingredients and provide emotional appeal to the patient and/or the patient's caregiver. Methods of administering such nutritional compositions to patients in need of same are also provided.

Abstract: A galenical form for the buccal transmucous administration of at least one active ingredient of the triptan family, includes at least: the active ingredient in basic form and in salt form, and a hydro-alcoholic solution that titrates at least 15 degrees of alcohol, whereby the active ingredient is present in a stable and complete state of dissolution in the hydro-alcoholic solution so as to allow a fast absorption of the active ingredient through the mucous membranes of the buccal cavity and/or the oropharynx. A process for the production of this galenical formulation as well as its use are described.

Abstract: Gastric retentive dosage forms for sustained release of acamprosate are described which may allow once- or twice-daily dosing for both acute and long-term treatment of a disorder including alcohol dependence, tinnitus, sleep apnea, Parkinson's disease, levodopa-induced dyskinesias in Parkinson's disease, Alzheimer's disease, Huntington's disease, Amyotrophic lateral sclerosis, Cortical spreading depression, migraine, schizophrenia, anxiety, tardive dyskinesia, spasticity, multiple sclerosis, various types pain, or binge eating. Methods of treatment using the dosage forms and methods of making the dosage forms are also described.

Abstract: A pouch-like structure useful for mechanically preventing distension and/or resisting dilation of the heart and for supporting the hearts function by controllable and paracrine support of a failing heart in a mammal, is composed at least partly of engineered tissue with genetically engineered cells other than cardiac myocytes. The genetically engineered cells contain a gene encoding a paracrine factor which is under control of an inducible promoter system or a heterologous promoter system. The preparation of the pouch-like structure may be used for therapeutic, disease modelling, and drug development applications.

Abstract: A method for stabilizing a poorly water-soluble drug-containing amphiphilic block copolymer micelle composition via simplified steps in short time is described. Also described is a stabilized poorly water-soluble drug-containing amphiphilic block copolymer micelle composition having improved stability.

Abstract: A lipid composition comprising racecadotril, at least one surfactant and a lipid.

Abstract: A composite particle including a core with at least one carrier material; a fluidizing material layer on the surface of the core; and an outer layer comprising nanoparticles of an ingestible material distributed in at least one matrix-forming material. A process of making the composite particles includes the steps of dry coating carrier particles with a fluidizing material; preparing a suspension of nanoparticles of an ingestible material distributed in a matrix-forming material; and fluid bed coating the carrier particles with the suspension. The process and products provide quick dissolving composite particles which can be used for delivery of poorly water soluble ingestible materials in suitable dosage forms. The process of the invention reduces or prevents particle agglomeration during fabrication of the composite particles to enable delivery and quick redispersion of nanoparticles of the ingestible material from a dosage form.

Abstract: The present invention relates to stable solid formulations of vitamin D3 and to processes for preparation of the same. The present invention provides stabilized compositions comprising vitamin D3 at least one lipophilic dispersant, one or more antioxidants, at least one adsorbent and one or more pharmaceutically acceptable excipients and further coated with a barrier coating.

Abstract: The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval.